These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with a vitamin E scaffold and the KALA peptide for use as an ex vivo dendritic cell-based cancer vaccine. Tateshita N; Miura N; Tanaka H; Masuda T; Ohtsuki S; Tange K; Nakai Y; Yoshioka H; Akita H J Control Release; 2019 Sep; 310():36-46. PubMed ID: 31386869 [TBL] [Abstract][Full Text] [Related]
6. Enhanced DNA vaccine potency by mannosylated lipoplex after intraperitoneal administration. Hattori Y; Kawakami S; Lu Y; Nakamura K; Yamashita F; Hashida M J Gene Med; 2006 Jul; 8(7):824-34. PubMed ID: 16625665 [TBL] [Abstract][Full Text] [Related]
7. Encapsulation of two different TLR ligands into liposomes confer protective immunity and prevent tumor development. Bayyurt B; Tincer G; Almacioglu K; Alpdundar E; Gursel M; Gursel I J Control Release; 2017 Feb; 247():134-144. PubMed ID: 28069554 [TBL] [Abstract][Full Text] [Related]
8. Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model tumor/self antigen. Hess PR; Boczkowski D; Nair SK; Snyder D; Gilboa E Cancer Immunol Immunother; 2006 Jun; 55(6):672-83. PubMed ID: 16133108 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant-pulsed mRNA vaccine nanoparticle for immunoprophylactic and therapeutic tumor suppression in mice. Islam MA; Rice J; Reesor E; Zope H; Tao W; Lim M; Ding J; Chen Y; Aduluso D; Zetter BR; Farokhzad OC; Shi J Biomaterials; 2021 Jan; 266():120431. PubMed ID: 33099060 [TBL] [Abstract][Full Text] [Related]
13. Paradoxical enhancement of CD8 T cell-dependent anti-tumor protection despite reduced CD8 T cell responses with addition of a TLR9 agonist to a tumor vaccine. Karan D; Krieg AM; Lubaroff DM Int J Cancer; 2007 Oct; 121(7):1520-8. PubMed ID: 17565748 [TBL] [Abstract][Full Text] [Related]
14. An indispensable role of type-1 IFNs for inducing CTL-mediated complete eradication of established tumor tissue by CpG-liposome co-encapsulated with model tumor antigen. Wakita D; Chamoto K; Zhang Y; Narita Y; Noguchi D; Ohnishi H; Iguchi T; Sakai T; Ikeda H; Nishimura T Int Immunol; 2006 Mar; 18(3):425-34. PubMed ID: 16415100 [TBL] [Abstract][Full Text] [Related]
15. Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells. Okada N; Saito T; Masunaga Y; Tsukada Y; Nakagawa S; Mizuguchi H; Mori K; Okada Y; Fujita T; Hayakawa T; Mayumi T; Yamamoto A Cancer Res; 2001 Nov; 61(21):7913-9. PubMed ID: 11691812 [TBL] [Abstract][Full Text] [Related]
16. Intranasal delivery of cationic liposome-protamine complex mRNA vaccine elicits effective anti-tumor immunity. Mai Y; Guo J; Zhao Y; Ma S; Hou Y; Yang J Cell Immunol; 2020 Aug; 354():104143. PubMed ID: 32563850 [TBL] [Abstract][Full Text] [Related]
17. Nanovaccine loaded with poly I:C and STAT3 siRNA robustly elicits anti-tumor immune responses through modulating tumor-associated dendritic cells in vivo. Luo Z; Wang C; Yi H; Li P; Pan H; Liu L; Cai L; Ma Y Biomaterials; 2015 Jan; 38():50-60. PubMed ID: 25457983 [TBL] [Abstract][Full Text] [Related]
18. The potential of antigen and TriMix sonoporation using mRNA-loaded microbubbles for ultrasound-triggered cancer immunotherapy. Dewitte H; Van Lint S; Heirman C; Thielemans K; De Smedt SC; Breckpot K; Lentacker I J Control Release; 2014 Nov; 194():28-36. PubMed ID: 25151979 [TBL] [Abstract][Full Text] [Related]
19. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines. Wang J; Saffold S; Cao X; Krauss J; Chen W J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528 [TBL] [Abstract][Full Text] [Related]
20. Multicomponent mannose-containing liposomes efficiently deliver RNA in murine immature dendritic cells and provide productive anti-tumour response in murine melanoma model. Markov OV; Mironova NL; Shmendel EV; Serikov RN; Morozova NG; Maslov MA; Vlassov VV; Zenkova MA J Control Release; 2015 Sep; 213():45-56. PubMed ID: 26134071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]